8-K: Expion360 Secures $15M At-The-Market Equity Offering

Expion360 Inc. has entered into an At-The-Market Issuance Sales Agreement with Aegis Capital Corp. to potentially sell up to $15.0 million of common stock.

Summary

• Expion360 Inc. (the "Company") entered into an At-The-Market (ATM) Issuance Sales Agreement with Aegis Capital Corp. on December 12, 2025.
• The agreement allows the Company to offer and sell, from time to time, up to an aggregate offering price of $15.0 million of its common stock (Placement Shares) through Aegis Capital Corp. as its sales agent.
• Sales of Placement Shares may be made by any method deemed an at-the-market offering, including on The Nasdaq Capital Market or in privately negotiated transactions.
• The Company is not obligated to sell any Placement Shares under the agreement.
• Net proceeds from the offering, if any, are intended for working capital and other general corporate purposes.
• The Company will pay Aegis Capital Corp. a commission of 2.0% of the aggregate gross proceeds from each sale of Placement Shares.
• The agreement will terminate upon the earlier of the issuance and sale of all Placement Shares or termination by either party, and has an eighteen-month anniversary automatic termination clause.

Sentiment

Score: 6

Explanation: The ATM offering provides a crucial, flexible funding mechanism for Expion360, addressing potential liquidity needs and supporting general corporate purposes. However, the potential for significant shareholder dilution and the inherent downward pressure on stock price from continuous 'at-the-market' sales introduce uncertainty. It's a neutral to slightly positive event as it addresses funding needs but comes with typical equity financing drawbacks.

Positives

• Provides Expion360 Inc. with a flexible and efficient mechanism to raise up to $15.0 million in capital as needed, without the immediate pressure of a traditional underwritten offering.
• The Company is not obligated to sell any specific amount of shares, allowing it to manage dilution and timing based on market conditions and funding requirements.
• Proceeds are designated for working capital and general corporate purposes, which can support ongoing operations, strategic initiatives, and overall financial stability.

Negatives

• The potential issuance of up to $15.0 million in common stock could lead to significant shareholder dilution, impacting the value of existing shares.
• Sales agent commissions of 2.0% and other legal expenses will reduce the net proceeds received by the Company from the offering.
• At-the-market sales can exert downward pressure on the Company's stock price due to the continuous availability of new shares in the market.

Risks

• Shareholder dilution is a significant risk as the Company may issue up to $15.0 million in new common stock, potentially decreasing the ownership percentage of current shareholders.
• The Company's ability to raise the full $15.0 million is subject to market demand and prevailing stock prices, meaning there is no guarantee of the amount of capital that can be raised.
• Continuous sales of common stock through an ATM facility can create volatility and downward pressure on the Company's share price.
• The Sales Agent is only required to use "commercially reasonable efforts" to sell shares, which does not guarantee successful placement or optimal pricing.
• The Company must maintain its eligibility for Form S-3 and have a sufficient number of authorized but unissued shares of common stock to fulfill the agreement.

Future Outlook

The Company intends to use any net proceeds from the offering for working capital and other general corporate purposes, indicating a focus on maintaining liquidity and funding ongoing operations or potential strategic initiatives.

Industry Context

At-The-Market (ATM) offerings are a common and flexible capital-raising tool for publicly traded companies, particularly small-cap firms, allowing them to access equity markets incrementally without the upfront costs and market disruption associated with traditional underwritten offerings. This strategy enables companies to raise capital opportunistically based on market conditions and specific funding needs, aligning with broader industry trends of diversified financing options.

Comparison to Industry Standards

• The 2.0% commission rate for the sales agent is within the typical range for ATM offerings, which often vary from 1% to 3% depending on the company size, offering size, and market conditions.
• The $15.0 million maximum offering size is a substantial amount for a company of Expion360's likely market capitalization (implied by the ATM structure), providing significant potential liquidity compared to many smaller ATM programs.
• The use of a Form S-3 registration statement is standard for well-established public companies, allowing for efficient and flexible 'shelf' offerings like this ATM program.

Stakeholder Impact

• Shareholders: Face potential dilution of their ownership stake as new common stock is issued. The stock price may experience volatility due to ongoing sales, but the capital raised could support the company's long-term operational stability and growth.
• Company: Gains a flexible and efficient source of capital to fund working capital and general corporate purposes, enhancing liquidity and operational flexibility.

Next Steps

• Expion360 Inc. may issue Placement Notices to Aegis Capital Corp. to initiate sales of common stock under the agreement.
• Aegis Capital Corp. will use commercially reasonable efforts to sell the Placement Shares as instructed by the Company.
• The Company will file prospectus supplements with the SEC to report the amount of Placement Shares sold, net proceeds, and commissions.
• The Company will continue to provide legal opinions and comfort letters to Aegis Capital Corp. on specified Representation Dates.

Key Dates

Recommendation

The At-The-Market (ATM) offering provides Expion360 with a vital, flexible funding mechanism, addressing potential liquidity needs and supporting general corporate purposes. This is a prudent move for operational continuity. However, the potential for significant shareholder dilution and the inherent downward pressure on stock price from continuous 'at-the-market' sales introduce a degree of uncertainty. While it secures future operational flexibility, it doesn't immediately signal strong growth or improved profitability. Therefore, a 'hold' recommendation is appropriate, awaiting more clarity on the actual deployment of funds and subsequent operational performance before adjusting the investment thesis.

Keywords

Expion360, XPON, At-The-Market, ATM Offering, Capital Raise, Equity Offering, Common Stock, Dilution, Nasdaq, Aegis Capital, SEC Filing, Form 8-K, Working Capital